Bright Green Corporation had a couple patent applications (US Pub. Nos. 20200107510 & 20200107511) for creating new varieties of cannabis plants, some considered GMO, published this month.
Application ‘510 teaches a method for generating new cannabis plants by chemical mutagenesis which is the application of particular chemicals to cell cultures to create changes in the DNA. Application ‘511 discloses how to select new varieties of cannabis plants from mutated cannabis cells that are producing cannabinoids.
As of now, no genetically modified cannabis is approved for sale or distribution. Trait Biosciences also holds IP for genetically modified cannabis targeting the food and beverage industry. Take a look through the cannabis sector IP landscape, conveniently labeled, with a membership to MagicNumberIP.com.
Cannabis is now legally being used to treat a wide variety of medical conditions, including chronic pain, alcoholism, anxiety, nausea (from chemotherapy) and epilepsy.
View Patent Forecast®
Top Corporations
News and Insights
Data Visualization
Cannabis is now legally being used to treat a wide variety of medical conditions, including chronic pain, alcoholism, anxiety, nausea (from chemotherapy) and epilepsy.